Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
AVROBIO, Inc. | Chief Scientific Officer | Stock Option (Right to Buy) | 125K | Jun 10, 2021 | Direct | ||
Krystal Biotech, Inc. | Director | Stock Option (Right to Buy) | 5K | Jun 30, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
KRYS | Krystal Biotech, Inc. | Jun 30, 2024 | 1 | $0 | 4 | Jul 1, 2024 | Director |
KRYS | Krystal Biotech, Inc. | Jun 30, 2023 | 1 | $0 | 4 | Jul 3, 2023 | Director |
KRYS | Krystal Biotech, Inc. | Jun 30, 2022 | 1 | $0 | 4 | Jul 1, 2022 | Director |
KRYS | Krystal Biotech, Inc. | Jun 30, 2021 | 1 | $0 | 4 | Jul 2, 2021 | Director |
AVRO | AVROBIO, Inc. | Jun 10, 2021 | 1 | $0 | 4 | Jun 14, 2021 | Chief Scientific Officer |